4//SEC Filing
WILSON JAMES N 4
Accession 0000950170-25-008963
CIK 0001088856other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:20 PM ET
Size
12.4 KB
Accession
0000950170-25-008963
Insider Transaction Report
Form 4
WILSON JAMES N
Director
Transactions
- Tax Payment
Common Stock
2025-01-22$59.03/sh−103,258$6,095,320→ 146,742 total - Exercise/Conversion
Stock option (right to buy)
2025-01-22−250,000→ 0 totalExercise: $3.29Exp: 2025-02-18→ Common Stock (250,000 underlying) - Exercise/Conversion
Common Stock
2025-01-22$3.29/sh+250,000$822,500→ 250,000 total - Other
Common Stock
2025-01-22+146,742→ 1,452,968 total(indirect: By Trust) - Gift
Common Stock
2025-01-22−146,742→ 0 total
Holdings
- 901,067(indirect: James and Pamela Wilson Family Partners)
Common Stock
Footnotes (4)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2025.
- [F2]Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.
- [F3]Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- [F4]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001236387
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 8:20 PM ET
- Size
- 12.4 KB